146 related articles for article (PubMed ID: 38419370)
1. Stenotrophomonas maltophilia skin infection in an immunocompetent patient: Primary cutaneous CD30+ T-cell lymphoproliferative disorder or pseudolymphoma?
Prete MD; Scarabello A; Lora V; Cota C
J Cutan Pathol; 2024 Jun; 51(6):403-406. PubMed ID: 38419370
[TBL] [Abstract][Full Text] [Related]
2. Stenotrophomonas maltophilia with histopathological features mimicking cutaneous gamma/delta T-cell lymphoma.
Kash N; Vin H; Danialan R; Prieto VG; Duvic M
Int J Infect Dis; 2015 Jan; 30():7-9. PubMed ID: 25462188
[TBL] [Abstract][Full Text] [Related]
3. [Primary cutaneous CD30+ lymphoproliferative disorders].
Calzado-Villarreal L; Polo-Rodríguez I; Ortiz-Romero PL
Actas Dermosifiliogr; 2010 Mar; 101(2):119-28. PubMed ID: 20223154
[TBL] [Abstract][Full Text] [Related]
4. A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine.
Han B; Liu H; Wang H
Dermatol Ther; 2022 Nov; 35(11):e15812. PubMed ID: 36088631
[TBL] [Abstract][Full Text] [Related]
5. Pseudoclonality in cutaneous pseudolymphomas: a pitfall in interpretation of rearrangement studies.
Böer A; Tirumalae R; Bresch M; Falk TM
Br J Dermatol; 2008 Aug; 159(2):394-402. PubMed ID: 18547309
[TBL] [Abstract][Full Text] [Related]
6. Eruption of lymphocyte recovery with atypical lymphocytes mimicking a primary cutaneous T-cell lymphoma: a series of 12 patients.
Hurabielle C; Sbidian E; Beltraminelli H; Bouchindhomme B; Chassagne-Clément C; Balme B; Bossard C; Delfau-Larue MH; Wolkenstein P; Chosidow O; Cordonnier C; Toma A; Pautas C; Ortonne N
Hum Pathol; 2018 Jan; 71():100-108. PubMed ID: 29107664
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic criteria of primary cutaneous B-cell lymphomas and pseudolymphomas.
Kerl H; Fink-Puches R; Cerroni L
Keio J Med; 2001 Dec; 50(4):269-73. PubMed ID: 11806505
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
9. Disseminated CD8-positive, CD30-positive cutaneous lymphoproliferative eruption with overlapping features of mycosis fungoides and primary cutaneous anaplastic large cell lymphoma following remote solitary lesional presentation.
Davick JJ; Mutgi KAJ; Wanat KA; Link BK; Liu V
J Cutan Pathol; 2017 Aug; 44(8):703-712. PubMed ID: 28497585
[TBL] [Abstract][Full Text] [Related]
10. Lymphoma- and leukemia-associated cutaneous atypical CD30+ T-cell reactions.
Su LD; Duncan LM
J Cutan Pathol; 2000 May; 27(5):249-54. PubMed ID: 10847550
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review.
Belloni-Fortina A; Montesco MC; Piaserico S; Bordignon M; Tona F; Feltrin G; Alaibac M
Acta Derm Venereol; 2009; 89(1):74-7. PubMed ID: 19197546
[TBL] [Abstract][Full Text] [Related]
12. CD30+ lymphoproliferative disorder in a patient with metastatic papillary thyroid carcinoma.
Udkoff J; Cohen PR
Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329586
[TBL] [Abstract][Full Text] [Related]
13. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
[TBL] [Abstract][Full Text] [Related]
14. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME
Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate-associated primary cutaneous CD30-positive cutaneous T-cell lymphoproliferative disorder: a case illustration and a brief review.
Claudino WM; Gibson B; Tse W; Krem M; Grewal J
Am J Blood Res; 2016; 6(1):1-5. PubMed ID: 27335685
[TBL] [Abstract][Full Text] [Related]
16. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
Magro CM; Olson LC; Fulmer CG
Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
[TBL] [Abstract][Full Text] [Related]
17. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders.
Sciallis AP; Law ME; Inwards DJ; McClure RF; Macon WR; Kurtin PJ; Dogan A; Feldman AL
Mod Pathol; 2012 Jul; 25(7):983-92. PubMed ID: 22388754
[TBL] [Abstract][Full Text] [Related]
18. Lymphoma or pseudolymphoma: A report of six cases and review of the literature.
Tian Z; Shiyu Z; Tao W; Li L; Yuehua L; Hongzhong J
Dermatol Ther; 2019 Jul; 32(4):e12807. PubMed ID: 30589489
[TBL] [Abstract][Full Text] [Related]
19. Stenotrophomonas maltophila cellulitis in an immunocompromised patient presenting with purpura, diagnosed on skin biopsy.
Gao Y; Minca EC; Procop GW; Bergfeld WF
J Cutan Pathol; 2016 Nov; 43(11):1017-1020. PubMed ID: 27406009
[TBL] [Abstract][Full Text] [Related]
20. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.
Bekkenk MW; Geelen FA; van Voorst Vader PC; Heule F; Geerts ML; van Vloten WA; Meijer CJ; Willemze R
Blood; 2000 Jun; 95(12):3653-61. PubMed ID: 10845893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
